These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

793 related items for PubMed ID: 15215253

  • 1. Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors.
    DiPerna G, Stack J, Bowie AG, Boyd A, Kotwal G, Zhang Z, Arvikar S, Latz E, Fitzgerald KA, Marshall WL.
    J Biol Chem; 2004 Aug 27; 279(35):36570-8. PubMed ID: 15215253
    [Abstract] [Full Text] [Related]

  • 2. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
    Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, Takeda K, Akira S.
    J Immunol; 2003 Oct 15; 171(8):4304-10. PubMed ID: 14530355
    [Abstract] [Full Text] [Related]

  • 3. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
    Stack J, Haga IR, Schröder M, Bartlett NW, Maloney G, Reading PC, Fitzgerald KA, Smith GL, Bowie AG.
    J Exp Med; 2005 Mar 21; 201(6):1007-18. PubMed ID: 15767367
    [Abstract] [Full Text] [Related]

  • 4. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
    Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, Cody MJ, Michalek SM, Rice NR, Vogel SN.
    J Immunol; 2003 Jan 01; 170(1):508-19. PubMed ID: 12496438
    [Abstract] [Full Text] [Related]

  • 5. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
    Jiang Z, Mak TW, Sen G, Li X.
    Proc Natl Acad Sci U S A; 2004 Mar 09; 101(10):3533-8. PubMed ID: 14982987
    [Abstract] [Full Text] [Related]

  • 6. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.
    Pomerantz JL, Baltimore D.
    EMBO J; 1999 Dec 01; 18(23):6694-704. PubMed ID: 10581243
    [Abstract] [Full Text] [Related]

  • 7. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.
    Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T.
    Nat Immunol; 2003 May 01; 4(5):491-6. PubMed ID: 12692549
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways.
    Han KJ, Su X, Xu LG, Bin LH, Zhang J, Shu HB.
    J Biol Chem; 2004 Apr 09; 279(15):15652-61. PubMed ID: 14739303
    [Abstract] [Full Text] [Related]

  • 9. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling.
    Bowie A, Kiss-Toth E, Symons JA, Smith GL, Dower SK, O'Neill LA.
    Proc Natl Acad Sci U S A; 2000 Aug 29; 97(18):10162-7. PubMed ID: 10920188
    [Abstract] [Full Text] [Related]

  • 10. Protein Kinase-Mediated Decision Between the Life and Death.
    Engin A.
    Adv Exp Med Biol; 2021 Aug 29; 1275():1-33. PubMed ID: 33539010
    [Abstract] [Full Text] [Related]

  • 11. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S.
    J Immunol; 2002 Dec 15; 169(12):6668-72. PubMed ID: 12471095
    [Abstract] [Full Text] [Related]

  • 12. TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways.
    Li L, Bin LH, Li F, Liu Y, Chen D, Zhai Z, Shu HB.
    J Cell Sci; 2005 Feb 01; 118(Pt 3):555-63. PubMed ID: 15657077
    [Abstract] [Full Text] [Related]

  • 13. Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7.
    Unterholzner L, Sumner RP, Baran M, Ren H, Mansur DS, Bourke NM, Randow F, Smith GL, Bowie AG.
    PLoS Pathog; 2011 Sep 01; 7(9):e1002247. PubMed ID: 21931555
    [Abstract] [Full Text] [Related]

  • 14. Ras participates in CpG oligodeoxynucleotide signaling through association with toll-like receptor 9 and promotion of interleukin-1 receptor-associated kinase/tumor necrosis factor receptor-associated factor 6 complex formation in macrophages.
    Xu H, An H, Yu Y, Zhang M, Qi R, Cao X.
    J Biol Chem; 2003 Sep 19; 278(38):36334-40. PubMed ID: 12867418
    [Abstract] [Full Text] [Related]

  • 15. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense.
    Harte MT, Haga IR, Maloney G, Gray P, Reading PC, Bartlett NW, Smith GL, Bowie A, O'Neill LA.
    J Exp Med; 2003 Feb 03; 197(3):343-51. PubMed ID: 12566418
    [Abstract] [Full Text] [Related]

  • 16. Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation.
    Sasai M, Oshiumi H, Matsumoto M, Inoue N, Fujita F, Nakanishi M, Seya T.
    J Immunol; 2005 Jan 01; 174(1):27-30. PubMed ID: 15611223
    [Abstract] [Full Text] [Related]

  • 17. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells.
    Shuto T, Xu H, Wang B, Han J, Kai H, Gu XX, Murphy TF, Lim DJ, Li JD.
    Proc Natl Acad Sci U S A; 2001 Jul 17; 98(15):8774-9. PubMed ID: 11438700
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function.
    Chang SJ, Hsiao JC, Sonnberg S, Chiang CT, Yang MH, Tzou DL, Mercer AA, Chang W.
    J Virol; 2009 May 17; 83(9):4140-52. PubMed ID: 19211746
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.